Polycystic kidney disease: From the bedside to the gene and back

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 4, 2001, Pages 533-542

  Grantham, Jared J ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE COURSE; GENE; GENETIC ANALYSIS; HUMAN; KIDNEY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOBIOGRAPHY; DISEASE MODELS, ANIMAL; HISTORY, 20TH CENTURY; HUMANS; MICE; MUTATION; POLYCYSTIC KIDNEY DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; UNITED STATES;

EID: 0034925405     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200107000-00008     Document Type: Review

References (98)

1. Fluid secretion in the nephron: Relation to renal failure
2. On the diagnosis of bilateral cystic kidney
3. Bilateral pofycystic disease of the kidneys
4. Composition of fluid in twelve cysts of a polycystic kidney. 1969
5. The pathogenesis of drug-induced renal cystic disease
6. Polycystic kidney disease: A predominance of giant nephrons
7. Polypoid and papillary epithelial hyperplasia: A potential cause of ductal obstruction in adult polycystic disease
8. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16
9. Linkage heterogeneity of autosomal dominant polycystic kidney disease
10. Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23
11. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease
12. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
13. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein
14. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains
15. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat
16. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1
17. The PKD1 gene product, "polycystin-1", is a tyrosine-phosphorylated protein that colocalizes with alpha2beta 1-integrin in focal clusters in adherent renal epithelia
18. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro
19. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein
20. Specific association of the gene product of PKD2 with the TRPC1 channel
21. A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans
22. PKD1 interacts with PKD2 through a probable coiled-coil domain
23. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2
24. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains
25. Distribution and developmentally regulated expression of murine polycystin
26. Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein
27. Polycystin expression is temporally and spatially regulated during renal development
28. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney
29. Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1
30. Polycystin-2 expression is developmentally regulated
31. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue
32. The role of the polycystins in kidney development
33. The vasculopathy of autosomal dominant polycystic kidney disease; insights from animal models
34. Murine Pkd1 is a developmentally regulated gene from morula to adulthood: Role in tissue condensation and patterning
35. Somatic mutation as mechanism for cyst formation in autosomal dominant polycystic kidney disease
36. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis
37. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I
38. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease
39. Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen
40. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation
41. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes
42. Somatic inactivation of Pkd2 results in polycystic kidney disease
43. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice
44. Polycystin 1 is required for the structural integrity of blood vessels
45. Vascular expression of polycystin-2
46. Localization of a murine recessive polycystic kidney disease mutation and modifying loci that affect disease severity
47. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice
48. Quantitative trait loci modulate renal cystic disease severity in the mouse bpk model
49. Morphogenetic clonal growth of kidney epithelial cell line MDCK
50. A new method for studying human polycystic kidney disease epithelia in culture
51. A hereditary model of slowly progressive polycystic kidney disease in the mouse
52. Autosomal-dominant polycystic kidney disease in the rat
53. The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease
54. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic
55. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney
56. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD
57. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse
58. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease
59. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor
60. Chloride and fluid secretion by cultured human polycystic kidney cells
61. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro
62. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells
63. A role for CFTR in human autosomal dominant polycystic kidney disease
64. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway
65. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells
66. Cyst formation and growth in autosomal dominant polycystic kidney disease
67. Role of obstruction in autosomal dominant polycystic kidney disease in rats
68. Elevated c-myc proto-oncogene expression in autosomal recessive polycystic kidney disease
69. Injury and development in polycystic kidney disease
70. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells
71. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype
72. The polycystic kidney disease 1 gene product modulates Wnt signaling
73. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins
74. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1
75. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2
76. Epithelial transport in polycystic kidney disease
77. Chloride and fluid secretion in polycystic kidney disease
78. Cystic diseases of the kidney: Role of adhesion molecules in normal and abnormal tubulogenesis
79. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions
80. 2+-permeable cation channel
81. 2+-permeable nonselective cation channel
82. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
83. Prognosis of adult onset polycystic kidney disease re-evaluated
84. Genetic analysis of modifying loci on mouse chromosome 1 that affect disease severity in a model of recessive PKD
85. Apoptosis and loss of renal tissue in polycystic kidney diseases
86. Modification of disease progression in rats with inherited polycystic kidney disease
87. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine
88. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
89. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease
90. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease
91. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography
92. pH-dependent accumulation of clindamycin in a polycystic kidney
93. Ciprofloxacin activity in cyst fluid from polycystic kidneys
94. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease
95. Intracranial aneurysms in autosomal dominant polycystic kidney disease
96. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease
97. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease by magnetic resonance angiography